
|Articles|June 19, 2019
- Psychiatric Times Vol 36, Issue 6
- Volume 36
- Issue 6
Patient Interviewing 101
Author(s)Richard M. Berlin, MD
Always ask the name of their dog.
Advertisement
Always ask the name of their dog.
Though silence is a tool that works,
the best interviews are dialogues.
Patients reveal more after Buster barks.
Though silence is a tool that works,
you want them engaged when you do your job.
Buster’s presence creates a spark-
their joy animates the dialogue.
You want them engaged when you do your job.
Each session spans an empathic arc
where joy animates the dialogue.
Patients reveal more after Buster barks.
Each session spans an empathic arc.
Let the interview unfold as dialogue
and patients will reveal the way they bark.
Always ask the name of their dog.
Articles in this issue
over 7 years ago
Overcoming Treatment Resistance: Can Pharmacogenetics Help?over 7 years ago
Treating Patients With Comorbid Anxiety and Diabetes Mellitusover 7 years ago
Chatbots: What Are They and Why Care?over 7 years ago
The FDA on ECT: Supporting a Vital Treatmentover 7 years ago
Serial Pleasuresover 7 years ago
Strategies to Facilitate a Positive Clinical Encounterover 7 years ago
Medication-Assisted Treatment on a Budget: Two You Should KnowAdvertisement
Related to this article

FDA approves monthly subcutaneous olanzapine LAI Weltruza, expanding schizophrenia treatment options and renewing debate on making long-acting injectables routine.

Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.

How past “untreatable” labels mislead psychiatry—and why measurement-informed care and difficult-to-treat depression replace today’s treatment-resistant mindset.

There is a question older than medicine, and perhaps older than philosophy, that psychiatry has largely avoided: What makes us human?

APSARD is preparing US adult ADHD guidelines, delivering long-awaited screening, diagnosis, and treatment recommendations as experts discuss the upcoming release.

Rethink “treatment-resistant depression” by adopting difficult-to-treat depression, verifying adequate trials, and stratifying drivers like trauma and inflammation to improve outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression
2
The New, Impending Adult ADHD Guidelines
3
Reframing “Treatment-Resistant” as “Difficult-To-Treat”
4
Relief Is Not Free: A Case Study of Athlete Cannabis Use
5


